by Jan G. Waldenström (Haematologica Series/Ferrata-Storti Foundation), 137 pp, ISBN 88-7002-654-X, II Pensiero Scientifico, Via Bradano, 3 c, 00199, Rome, Italy; fax: (6)86207160.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The name of Jan Waldenström, professor emeritus of medicine at the University of Lund and physician-in-chief at Malmö Hospital in Sweden, is inextricably associated with the disease that bears his name, Waldenström macroglobulinemia, a disorder of unknown etiology in which there is an uncontrolled proliferation of plasma cells and lymphocytes leading to a marked increase in IgM protein in human serum. The disease, even when treated, almost invariably leads to a fatal outcome. But Waldenström's reputation extends far beyond the eponymous recognition of macroglobulinemia. His long and distinguished career in medicine has been characterized by clinical investigation of a high order and in diverse fields.
"Is it becoming canonical that the biological basis of human disease can be elucidated only by a reductionistic approach and that little can be learned from patient-oriented research?"
We live at a time when there is a lamentable dearth of clinical investigators, a situation recently
Beam A. Reflections and Recollections From a Long Life With Medicine. JAMA. 1995;274(2):183-184. doi:10.1001/jama.1995.03530020101044